Safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): Interim results of a post-marketing surveillance study.
about
Baseline characteristics and interim (3-month) efficacy and safety data from STELLA-LONG TERM, a long-term post-marketing surveillance study of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice.Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus.An overview of the effect of sodium glucose cotransporter 2 inhibitor monotherapy on glycemic and other clinical laboratory parameters in type 2 diabetes patientsRationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.SGLT2 inhibitors in the pipeline for the treatment of diabetes mellitus in Japan.Real-world evidence for the safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): final results of a post-marketing surveillance study.Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics.Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study).
P2860
Q31117903-80D29EAF-FE76-445B-8064-6AF0746319A7Q33763305-B65C4D5C-7DB3-4681-BEDD-D01E6E3ABDF3Q37114983-1C429063-CC68-4A34-9DFD-8E73415DF7B5Q37251449-AA686367-F1C5-4289-93AC-B85E62BFCE14Q38824557-145E06C1-7579-4EFE-B13B-B033AFD5ECEAQ39540260-C6AE30B3-987A-44BC-8F9B-E5CA5AD3BA06Q47995019-76806B12-799B-44A4-AD24-0B0A370C721CQ51744128-B2B17E12-4FF8-4567-9F3A-9F38D90B35FB
P2860
Safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): Interim results of a post-marketing surveillance study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Safety of ipragliflozin in eld ...... -marketing surveillance study.
@en
type
label
Safety of ipragliflozin in eld ...... -marketing surveillance study.
@en
prefLabel
Safety of ipragliflozin in eld ...... -marketing surveillance study.
@en
P2093
P2860
P1476
Safety of ipragliflozin in eld ...... -marketing surveillance study.
@en
P2093
Haruko Sugamori
Ichiro Nakamura
Koutaro Yokote
Yasuo Terauchi
P2860
P304
P356
10.1517/14656566.2016.1145668
P407
P577
2016-01-22T00:00:00Z